A Selective Inhibitor Reveals Pi3Kgamma Dependence of T(H)17 Cell Differentiation.
Giovanna Bergamini(Heidelberg Engineering (Germany)), Gitte Neubauer, R Mangano, Satoko Shimamura, Toby Mathieson, Jessica Perrin(GlaxoSmithKline (Germany)), Carola Doce(GlaxoSmithKline (Germany)), Thilo Werner(GlaxoSmithKline (Germany)), Kathryn M. Bell(CellCentric (United Kingdom)), Alison O’Mahony(Goldfinch Bio (United States)), Nigel G. Ramsden(CellCentric (United Kingdom)), Oliver Rausch(Mission Therapeutics (United Kingdom)), Faı̈za Rharbaoui, Carsten Hopf(Technische Hochschule Mannheim), Marcus Bantscheff(Roche (Switzerland)), Christina Rau(GlaxoSmithKline (Germany)), Daniel Leggate(CellCentric (United Kingdom)), Ivan Plavec(Genesys (United States)), Andrew D. Cansfield(CellCentric (United Kingdom)), Katie Ellard(CellCentric (United Kingdom)), Gerard Drewes(Unknown), Friedrich Reinhard(GlaxoSmithKline (Germany)), Kilian J. Müller, Emilio Hirsch(University of Turin), Mikhail M. Savitski(European Molecular Biology Laboratory)
Cited by 24
Related Papers
Mass-spectrometry-based draft of the human proteome
|Nature|2014|1.9k
Quantitative mass spectrometry in proteomics: a critical review
|Analytical and Bioanalytical Chemistry|2007|1.7k
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
|Nature|2011|1.5k
Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present
|Analytical and Bioanalytical Chemistry|2012|801